These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study. McGuinness B; Fuchs M; Barrett SL; Passmore AP; Johnston JA J Alzheimers Dis; 2016; 49(4):1095-103. PubMed ID: 26639974 [TBL] [Abstract][Full Text] [Related]
8. Decreased phospholipase A2 activity in Alzheimer brains. Gattaz WF; Maras A; Cairns NJ; Levy R; Förstl H Biol Psychiatry; 1995 Jan; 37(1):13-7. PubMed ID: 7893853 [TBL] [Abstract][Full Text] [Related]
9. Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease. Liang QC; Jin D; Li Y; Wang RT Platelets; 2014; 25(6):433-8. PubMed ID: 24175580 [TBL] [Abstract][Full Text] [Related]
10. Platelet MAO-B activity as a marker of behavioural characteristics in dementia disorders. Parnetti L; Reboldi GP; Santucci C; Santucci A; Gaiti A; Brunetti M; Cecchetti R; Senin U Aging (Milano); 1994 Jun; 6(3):201-7. PubMed ID: 7993928 [TBL] [Abstract][Full Text] [Related]
11. Determinants of platelet-leukocyte aggregation and platelet activation in stroke. Schmalbach B; Stepanow O; Jochens A; Riedel C; Deuschl G; Kuhlenbäumer G Cerebrovasc Dis; 2015; 39(3-4):176-80. PubMed ID: 25720421 [TBL] [Abstract][Full Text] [Related]
12. Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia. Palmer JC; Kehoe PG; Love S Neuropathol Appl Neurobiol; 2010 Oct; 36(6):487-97. PubMed ID: 20345647 [TBL] [Abstract][Full Text] [Related]
13. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients. Talib LL; Hototian SR; Joaquim HP; Forlenza OV; Gattaz WF Eur Arch Psychiatry Clin Neurosci; 2015 Dec; 265(8):701-6. PubMed ID: 25920742 [TBL] [Abstract][Full Text] [Related]
14. The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease. Forlenza OV; Schaeffer EL; Gattaz WF J Neural Transm (Vienna); 2007 Feb; 114(2):231-8. PubMed ID: 17131232 [TBL] [Abstract][Full Text] [Related]
15. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314 [TBL] [Abstract][Full Text] [Related]
16. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia. Yu PH Med Hypotheses; 2001 Aug; 57(2):175-9. PubMed ID: 11461168 [TBL] [Abstract][Full Text] [Related]
17. Alzheimer's mechanisms in ischemic brain degeneration. Pluta R; Ułamek M; Jabłoński M Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340 [TBL] [Abstract][Full Text] [Related]
18. Clinical diagnosis of vascular dementia. Nagata K; Saito H; Ueno T; Sato M; Nakase T; Maeda T; Satoh Y; Komatsu H; Suzuki M; Kondoh Y J Neurol Sci; 2007 Jun; 257(1-2):44-8. PubMed ID: 17445833 [TBL] [Abstract][Full Text] [Related]
19. Alzheimer and platelets: low-density platelet populations reveal increased serotonin content in Alzheimer type dementia. Milovanovic M; Eriksson K; Winblad B; Nilsson S; Lindahl TL; Post C; Järemo P Clin Biochem; 2014 Oct; 47(15):51-3. PubMed ID: 25041722 [TBL] [Abstract][Full Text] [Related]
20. Reduction of platelet phospholipase C activity in patients with Alzheimer disease. Matsushima H; Shimohama S; Fujimoto S; Takenawa T; Kimura J Alzheimer Dis Assoc Disord; 1995; 9(4):213-7. PubMed ID: 8749610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]